【レポートの概要（一部）】
Table of Content
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Carcinoembryonic Antigen Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects
3.3 Carcinoembryonic antigen – Market dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing prevalence of cancer
3.3.1.2 Increasing geriatric population
3.3.1.3 Increasing demand for minimally invasive diagnostic procedures
3.3.1.4 Growing healthcare expenditure triggering the need for effective diagnostic procedure for cancer
3.3.1.5 Increasing usage of combination biomarkers
3.3.1.6 Usage of CEA at various stages of cancer
3.3.2 Market Restraint Analysis
3.3.2.1 Inefficiency to diagnose cancer at early stages
3.3.2.2 Presence of complicated regulatory framework
3.4 Key Opportunities Prioritized
3.5 Industry analysis – Porter’s
3.6 Carcinoembryonic Antigen – PESTEL Analysis
Chapter 4 Carcinoembryonic Antigen Application Outlook
4.1 Carcinoembryonic antigen revenue share by application, 2014 & 2022
4.2 Colorectal cancer market
4.2.1 Colorectal cancer market, 2012 – 2022 (USD Million)
4.3 Pancreatic cancer
4.3.1 Pancreatic cancer market, 2012 – 2022 (USD Million)
4.4 Ovarian cancer
4.4.1 Ovarian cancer market, 2012 – 2022 (USD Million)
4.5 Breast cancer
4.5.1 Breast cancer market, 2012 – 2022 (USD Million)
4.6 Thyroid cancer
4.6.1 Thyroid cancer market, 2012 – 2022 (USD Million)
4.7 Others
4.7.1 Others market, 2012 – 2022 (USD Million)
Chapter 5 Carcinoembryonic Antigen Regional Outlook
5.1 Carcinoembryonic antigen market share, by region, 2014 & 2022
5.2 North America
5.2.1 North America market, by application, 2012 – 2022 (USD Million)
5.2.2 U.S.
5.2.3 U.S. market, by application, 2012 – 2022 (USD Million)
5.2.4 Canada
5.2.5 Canada market, by application, 2012 – 2022 (USD Million)
5.3 Europe
5.3.1 Europe market, by application, 2012 – 2022 (USD Million)
5.3.2 Germany
5.3.3 Germany market, by application, 2012 – 2022 (USD Million)
5.3.4 France
5.3.5 France market, by application, 2012 – 2022 (USD Million)
5.3.6 Spain
5.3.7 Spain market, by application, 2012 – 2022 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific market, by application, 2012 – 2022 (USD Million)
5.4.2 Japan
5.4.3 Japan market, by application, 2012 – 2022 (USD Million)
5.4.4 China
5.4.5 China market, by application, 2012 – 2022 (USD Million)
5.4.6 India
5.4.7 India market, by application, 2012 – 2022 (USD Million)
5.5 Latin America
5.5.1 Latin America market, by application, 2012 – 2022 (USD Million)
5.5.2 Mexico
5.5.3 Mexico market, by application, 2012 – 2022 (USD Million)
5.5.4 Brazil
5.5.5 Brazil market, by application, 2012 – 2022 (USD Million)
5.6 MEA
5.6.1 MEA market, by application, 2012 – 2022 (USD Million)
5.6.2 South Africa
5.6.3 South Africa market, by application, 2012 – 2022 (USD Million)
Chapter 6 Competitive Landscape
6.1 Quest Diagnostics
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Roche Diagnostics
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Abbott Diagnostics
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 GenWay Biotech Inc.
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Correlogic Systems, Inc.
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
List of Tables
TABLE 1 Carcinoembryonic antigen – Industry summary & Critical Success Factors (CSFs)
TABLE 2 Global market , by application, 2012 – 2022 (USD Million)
TABLE 3 Global carcinoembryonic antigen market, by region, 2012 – 2022 (USD Million)
TABLE 4 Carcinoembryonic antigen – Key market driver analysis
TABLE 5 Global cancer incidences in 2012
TABLE 6 North America cancer incidences in 2012
TABLE 7 Europe cancer incidences in 2012
TABLE 8 Asia cancer incidences in 2012
TABLE 9 Africa cancer incidences in 2012
TABLE 10 Australia and New Zealand cancer incidences in 2012
TABLE 11 North America geriatric population (Over 60 Years) (Million) 2012 – 2022
TABLE 12 Europe geriatric population (Over 60 Years) (Million) 2012 – 2022
TABLE 13 Asia geriatric population (Over 60 Years) (Million) 2012 – 2022
TABLE 14 Latin America geriatric population (Over 60 Years) (Million) 2012 – 2022
TABLE 15 Africa geriatric population (Over 60 Years)(Million) 2012 – 2022
TABLE 16 Healthcare Expenditure, 2012
TABLE 17 Carcinoembryonic antigen – Key market restraint analysis
TABLE 18 North America market, by application, 2012 – 2022 (USD Million)
TABLE 19 U.S. carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 20 Canada market, by application, 2012 – 2022 (USD Million)
TABLE 21 Europe market, by application, 2012 – 2022 (USD Million)
TABLE 22 Germany market, by application, 2012 – 2022 (USD Million)
TABLE 23 France market, by application, 2012 – 2022 (USD Million)
TABLE 24 Spain carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 25 Asia Pacific market, by application, 2012 – 2022 (USD Million)
TABLE 26 Japan carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 27 China carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 28 India carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 29 Latin America market, by application, 2012 – 2022 (USD Million)
TABLE 30 Mexico market, by application, 2012 – 2022 (USD Million)
TABLE 31 Brazil carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 32 MEA carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)
TABLE 33 South Africa market, by application, 2012 – 2022 (USD Million)
List of Figures
FIG. 1 Carcinoembryonic antigen : Market segmentation
FIG. 2 Global Carcinoembryonic Antigen market, 2012 – 2022 (USD Million)
FIG. 3 Carcinoembryonic antigen : Market dynamics
FIG. 4 Global geriatric population, 2012 – 2022 (Million)
FIG. 5 Key opportunities prioritized
FIG. 6 Carcinoembryonic antigen market – Porter’s analysis
FIG. 7 Carcinoembryonic antigen market – PESTEL analysis
FIG. 8 Carcinoembryonic antigen revenue share by application, 2014 & 2022
FIG. 9 Colorectal cancer market, 2012 – 2022 (USD Million)
FIG. 10 Pancreatic cancer market, 2012 – 2022 (USD Million)
FIG. 11 Ovarian cancer market, 2012 – 2022 (USD Million)
FIG. 12 Breast cancer market, 2012 – 2022 (USD Million)
FIG. 13 Thyroid cancer market, 2012 – 2022 (USD Million)
FIG. 14 Others market, 2012 – 2022 (USD Million)
FIG. 15 Carcinoembryonic antigen market share, by region, 2014 & 2022
FIG. 16 North America Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 17 U.S. Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 18 Europe Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 19 Germany Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 20 France Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 21 Spain Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 22 Asia Pacific Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 23 India Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 24 China Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 25 Japan Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 26 Latin America Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 27 Mexico Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 28 Brazil Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
FIG. 29 MEA Carcinoembryonic antigen market, 2012 – 2022 (USD Million)
【レポート販売概要】
■ タイトル：がん胎児性抗原の世界市場分析：用途別（結腸直腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん）、セグメント予測■ 英文：Carcinoembryonic Antigen (CEA) Market Analysis by Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer) and Segment Forecasts To 2022
■ 発行日：2015年6月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707162
■ 調査対象地域：グローバル
- マスク検査装置の世界市場2016-2020About the Mask Inspection Equipment Market The semiconductor market is shifting toward complex and miniaturized devices. Semiconductor device manufacturers need higher inspection sensitivity as they move toward lower node sizes (10nm and beyond). The migration will introduce complex structures and designs, as well as new materials. Mask inspection equipment is fab equipment that is used, before li …
- 世界のセメント市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of cement, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing cement production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: cement production …
- 世界の海水淡水化市場：多段フラッシュ方式、多重効用法（MED）、逆浸透法、電気透析法About Water Desalination Water desalination refers to the removal of salt and other minerals from saline water. It is used to address fresh water supplies amidst increasing population, industrialization, and pollution. Desalinated water can be used in water drought-hit areas as alternative water source to increase water production yield. Water scarcity in various parts of the globe has become one …
- スペインの滅菌器市場見通し（～2021）Spain Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Spain Sterilization Equipment Market Outlook to 2021", provides key market data on the Spain Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and Ultr …
- Pharmaceuticals Monthly Deals Analysis: October 2013 – Partnerships, Licensing, Investments and M&A TrendsPharmaceuticals Monthly Deals Analysis: October 2013 - Partnerships, Licensing, Investments and M&A Trends Summary GlobalData's “Pharmaceuticals Monthly Deals Analysis: October 2013 - Partnerships, Licensing, Investments and M&A Trends” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry …
- 世界の臨床化学及び免疫診断検査市場：課題、新技術、競争環境“New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and …
- クロスフローメンブレンの世界市場：逆浸透膜濾過、限外濾過、精密濾過、ナノ濾過About Cross Flow Membrane Cross flow filtration, also known as tangential flow filtration, is a process in which the feed flows parallel to or tangentially across the surface of the membrane, rather than perpendicular to it, as is the case in conventional filtration processes. The principal advantages of cross flow filtration are: • Longer duration of filtration as the filter cake is constantly wa …
- 潤滑剤の世界市場：鉱油潤滑剤、合成潤滑剤、生物由来潤滑剤、グリースThe global lubricants market is projected to reach USD 166.59 Billion by 2021, registering a CAGR of 2.4% between 2016 and 2021. This rapid growth in the automotive industry in Asia-Pacific is a key driver of the lubricants market. More than 60% of lubricants are consumed by the transportation application segment in 2015. Also, the rapid growth of various manufacturing industry in emerging nations …
- Fallopian Tube Cancer：グローバル臨床試験レビューH2, 2013Fallopian Tube Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2013" provides data on the Fallopian Tube Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fallopian Tube Cancer. It includes an overview of the trial numbers and the …
- クロマトグラフィー器具の世界市場：装置（LC、GC、SFC、TLC、オートサンプラ、検出器、フラクションコレクター、ポンプ）、消耗品Over the years, the chromatography instruments market has witnessed various technological advancements to meet the needs of biotechnology and biopharmaceutical companies; food and beverage, chemical, and semiconductor industries; and environmental testing. These advancements have led to the development of miniaturized, automated, and computerized devices. These technological advancements have incr …
- データレイクの世界市場：データ・ディレクトリー、データ統合、データレイク分析、データ可視化The data lakes market size is expected to grow from USD 2.53 Billion in 2016 to USD 8.81 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 28.3% during the forecast period. The major growth drivers of the market include need for increased business agility and accessibility, increasing adoption of Internet of Things (IoT), potential for in-depth insights to drive competitive advantage, an …
- 小売り用ガラスパッケージの世界市場2017-2021：アルコール飲料用、ノンアルコール飲料用、食品用、パーソナルケア用About Retail Glass Packaging Glass packaging is convenient to use, is sturdy, and provides a firm grip. Glass is used as the primary material for packaging a variety of products due to its thermal and chemical resistance. It can withstand temperatures up to 380º F. For instance, borosilicate glass material is water-resistant and neutral to acids and concentrated acid mixtures (including chlorine, …
- ゲームの世界市場2016-2020About Gaming Earlier, gaming was limited to board games and handheld video games. The growing popularity of PCs and electronic devices aided by the increased internet penetration has led to the development and commercialization of games. Consumers are now heavily dependent on interactive entertainment such as video games. Video games are electronic games that require a video interface for human in …
- 太陽光発電式UAV（無人機）の世界市場2016-2020About the Solar-Powered Unmanned Aerial Vehicle (UAV) Market UAVs are commonly referred to as drones or remotely piloted aircraft. These vehicles are either operated by remote control from the ground or by onboard computers. Conventional UAVs range from large-sized UAVs employed for tactical missions and powered by an internal combustion engine, to small electric-powered UAVs. However, new technol …
- 幹細胞治療の世界市場展望Stem cells are specialized cells that can differentiate into other cells without losing their identity. They have been found to be present in animals as well as humans and most of the work has been done on mice. Investigators have found that stem cells are part of repair system and helps in maintaining the normal bodily functions. They divide to give rise to two cells out of which one remains the …
